Jul 11, 2022 Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment
Jun 28, 2022 Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update
Jun 21, 2022 Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022
May 2, 2022 Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants
Jan 31, 2022 Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022
Nov 2, 2021 Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021